Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids

By Kirsner Robert S.   Heffernan Michael P.   Antaya Richard  

Acta Dermato-Venereologica, Vol. 90, Iss. 1, 2010-01 ,pp. : 58-64

Medical Journals Limited

Access to resources Recommend Favorite

Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: Results from two randomized, multicentre, comparative studies

By Reitamo Sakari   Allsopp Richard  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 34-44

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis

By Luger TA   Lahfa M   Fölster-Holst R   Gulliver WP   Allen R   Molloy S   Barbier N   Paul C   Bos JD  

Journal of Dermatological Treatment, Vol. 15, Iss. 3, 2004-06 ,pp. : 169-178

Informa Healthcare

Access to resources Recommend Favorite

Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year

By Van Leent Edwin   De Vries Henry   Ebelin Marie-Eve   Burtin Pascale   Scott Graham   Bos Jan  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 19-22

Informa Healthcare

Access to resources Recommend Favorite

One-year Treatment with 0.1% Tacrolimus Ointment versus a Corticosteroid Regimen in Adults with Moderate to Severe Atopic Dermatitis: A Randomized, Double-blind, Comparative Trial

By Mandelin Johanna   Remitz Anita   Virtanen Hannele   Reitamoskin Sakari  

Acta Dermato-Venereologica, Vol. 90, Iss. 2, 2010-02 ,pp. : 170-174

Medical Journals Limited

Access to resources Recommend Favorite